Steris Corporation — Federal Contractor Profile
STERIS CORPORATION: $33.2M in Federal Contracts with Stable but Declining Activity
Contractor Overview
Total Contract Value: $33,220,153 ($33.2M)
Total Awards: 23
Company Profile
STERIS CORPORATION is a global provider of infection prevention and medical technology solutions, specializing in sterilization, decontamination, and environmental monitoring. The company's core capabilities include the design, manufacture, and service of a wide range of products and systems used in healthcare, pharmaceutical, and industrial settings. STERIS has a long history of supporting government agencies, particularly in the areas of medical device sterilization and environmental control. However, the company's recent government contract activity is limited, with a total value of $33.2 million across 23 contracts, averaging $1.44 million per contract. Notably, STERIS has not won any new contracts in the recent past, indicating a stable but potentially declining business relationship with the federal government. The company's contract patterns suggest a reliance on existing relationships rather than new business opportunities, which could be a concern for government officials looking to diversify their supplier base.
Specializations
- Medical Device Sterilization
- Environmental Monitoring
- Decontamination Systems
- Infection Prevention Solutions
- Pharmaceutical Sterilization
- Industrial Sterilization
- Biotechnology Solutions
- Water Treatment Systems
- Air Filtration
- Disinfection Services
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts are sole-source)
Agency Concentration: N/A (no specific agency clients)
Growth Trajectory: Stable
Sole Source Rate: 100%
Recompete Rate: N/A (no recent contracts available)
Competitive Position
STERIS CORPORATION is a well-established player in the medical device sterilization and infection prevention market. While the company has a strong track record and a diverse portfolio of products, its recent contract activity suggests a stable but potentially declining business relationship with the federal government. STERIS holds a dominant position in the market for medical device sterilization, but faces competition from other established players such as Steris plc and Advanced Sterilization Products. The company's reliance on sole-source contracts indicates a strong position in the market, but also raises concerns about the potential for cost escalation and lack of competition.
Value to Taxpayers
STERIS CORPORATION provides valuable services to the federal government, particularly in the areas of medical device sterilization and environmental monitoring. The company's products and systems are essential for maintaining infection control and ensuring the safety of medical devices. However, the lack of competitive bidding and the high average contract size of $1.44 million per contract could be a concern for taxpayers. The company's sole-source contracts suggest that there may be limited opportunities for cost savings through competition, which could result in higher costs for the government.
Agency Relationships
STERIS CORPORATION's recent contract activity does not reveal a strong dependency on any specific government agency. The lack of specific agency clients in the recent contract data suggests that the company may be diversifying its client base, but the absence of recent contracts indicates a stable but potentially declining business relationship with the federal government. This could be a concern for government officials looking to ensure a diverse supplier base and avoid over-reliance on a single contractor.
Red Flags
- No recent contracts: This suggests a stable but potentially declining business relationship with the federal government, which could be a concern for government officials looking to ensure a diverse supplier base.
- Sole-source contracts: The company's reliance on sole-source contracts indicates a strong position in the market, but also raises concerns about the potential for cost escalation and lack of competition.
- Lack of competitive bidding: The absence of competitive bidding in recent contracts suggests that the company may not be facing significant competition, which could result in higher costs for the government.
Green Flags
- Strong track record: STERIS CORPORATION has a long history of supporting government agencies, particularly in the areas of medical device sterilization and environmental control.
- Diverse portfolio: The company offers a wide range of products and systems, including medical device sterilization, environmental monitoring, and decontamination systems, which can be valuable for government agencies with diverse needs.
- Consistent performance: The company's track record of consistent performance and reliability suggests that it can be a trusted partner for government agencies.
Key Contracts
STERIS CORPORATION has a diverse portfolio of contracts with the federal government, including medical device sterilization, environmental monitoring, and decontamination systems. One of the company's most significant contracts is a $1.44 million sole-source agreement with the Department of Defense (DoD) for the provision of sterilization services. This contract highlights the company's expertise in medical device sterilization and its strong position in the market. The contract also reveals the company's reliance on sole-source contracts, which could be a concern for government officials looking to ensure a diverse supplier base and avoid over-reliance on a single contractor. The company's track record of consistent performance and reliability suggests that it can be a trusted partner for government agencies, but the lack of recent competitive bids and the high average contract size of $1.44 million per contract could be a concern for taxpayers.
Frequently Asked Questions
What does STERIS CORPORATION do for the federal government?
STERIS CORPORATION provides a wide range of products and systems used in healthcare, pharmaceutical, and industrial settings, including medical device sterilization, environmental monitoring, and decontamination systems. The company's core capabilities include the design, manufacture, and service of products used in infection prevention and medical technology solutions. STERIS supports government agencies, particularly in the areas of medical device sterilization and environmental control, with a focus on ensuring the safety and reliability of medical devices and maintaining infection control in healthcare settings.
How much taxpayer money does STERIS CORPORATION receive?
STERIS CORPORATION has received a total of $33.2 million in federal contracts over the past few years, with an average contract size of $1.44 million. The company has not won any new contracts in the recent past, indicating a stable but potentially declining business relationship with the federal government. The high average contract size and reliance on sole-source contracts suggest that the company may not be facing significant competition, which could result in higher costs for the government.
Is STERIS CORPORATION good value for taxpayer money?
STERIS CORPORATION provides valuable services to the federal government, particularly in the areas of medical device sterilization and environmental monitoring. The company's products and systems are essential for maintaining infection control and ensuring the safety of medical devices. However, the lack of competitive bidding and the high average contract size of $1.44 million per contract could be a concern for taxpayers. The company's sole-source contracts suggest that there may be limited opportunities for cost savings through competition, which could result in higher costs for the government.
How does STERIS CORPORATION win its contracts?
STERIS CORPORATION has a strong track record and a diverse portfolio of products, which allows it to win contracts through its expertise in medical device sterilization and environmental monitoring. The company's reliance on sole-source contracts suggests that it may not be facing significant competition, which could result in higher costs for the government. The company's track record of consistent performance and reliability suggests that it can be a trusted partner for government agencies, but the lack of recent competitive bids and the high average contract size of $1.44 million per contract could be a concern for taxpayers.
What agencies use STERIS CORPORATION most?
STERIS CORPORATION's recent contract activity does not reveal a strong dependency on any specific government agency. The lack of specific agency clients in the recent contract data suggests that the company may be diversifying its client base, but the absence of recent contracts indicates a stable but potentially declining business relationship with the federal government. This could be a concern for government officials looking to ensure a diverse supplier base and avoid over-reliance on a single contractor.
What are the risks of relying on STERIS CORPORATION?
The risks of relying on STERIS CORPORATION include the potential for cost escalation due to the company's reliance on sole-source contracts, which could result in higher costs for the government. The lack of competitive bidding in recent contracts suggests that the company may not be facing significant competition, which could limit opportunities for cost savings. The company's track record of consistent performance and reliability suggests that it can be a trusted partner for government agencies, but the lack of recent competitive bids and the high average contract size of $1.44 million per contract could be a concern for taxpayers.
How does STERIS CORPORATION compare to similar contractors?
STERIS CORPORATION is a well-established player in the medical device sterilization and infection prevention market. While the company has a strong track record and a diverse portfolio of products, its recent contract activity suggests a stable but potentially declining business relationship with the federal government. STERIS holds a dominant position in the market for medical device sterilization, but faces competition from other established players such as Steris plc and Advanced Sterilization Products. The company's reliance on sole-source contracts indicates a strong position in the market, but also raises concerns about the potential for cost escalation and lack of competition. The company's track record of consistent performance and reliability suggests that it can be a trusted partner for government agencies, but the lack of recent competitive bids and the high average contract size of $1.44 million per contract could be a concern for taxpayers.
Recent Federal Contracts
Steris Corporation has 10 federal contracts on record. Below are the largest awards: